Add BrightSurf on Google Email

New microfluidic device reveals how the shape of a tumour can predict a cancer’s aggressiveness

Researchers at University of Toronto have developed a new microfluidic platform, ReSCUE, that allows for unprecedented control and manipulation of tumor shapes. This enables the formation, release, and transfer of patient-derived tumoroids, providing insights into how tumor shape predicts cancer cell behavior and aggressiveness.

New imaging technique to improve head and neck cancer surgery

Researchers developed a new imaging technique using fluorescence-guided surgery to enhance visibility of tumors and nerves during head and neck cancer surgery. The technique uses two near-infrared fluorophores, one for tumors and another for facial nerves, allowing for clear differentiation between cancerous tissues and nerves.

SourceSPIE--International Society for Optics and Photonics·JournalJournal of Biomedical Optics·DateNov 7, 2024

New anti-cancer agent works without oxygen

A new anti-cancer agent has been developed that targets glutathione in cancer cells, switching it off and causing tumor shrinkage. The catalyst-based therapy accumulates specifically in tumor tissue, showing promising results in animal studies and potential for further human trials.

SourceRuhr-University Bochum·JournalNature Communications·TypeExperimental study·DateOct 31, 2024

Fluorescent molecules to illuminate life: simplified synthesis with formaldehyde

A research team has developed a simplified synthesis method for organic fluorophores using formaldehyde, reducing molecular size and increasing atomic efficiency. The new technique can also be applied to in vivo environments, showing promise for life sciences research and diagnostics applications.

SourcePohang University of Science & Technology (POSTECH)·JournalAngewandte Chemie International Edition·DateSep 30, 2024

Medical imaging breakthrough could transform cancer and arthritis diagnosis

A new hand-held scanner can generate highly detailed 3D images in seconds, paving the way for earlier disease diagnosis. The technology uses laser-generated ultrasound waves to visualize subtle changes in blood vessels, helping inform patient care and diagnose conditions like cancer and cardiovascular disease.

SourceUniversity College London·JournalNature Biomedical Engineering·TypeExperimental study·DateSep 30, 2024

Antidepressant shows promise for treating brain tumors

Researchers at ETH Zurich have found an antidepressant, vortioxetine, effective against glioblastomas, a particularly aggressive brain tumor with no cure. The drug's ability to cross the blood-brain barrier and trigger a signalling cascade makes it promising for treating this deadly tumour.

SourceETH Zurich·JournalNature Medicine·TypeComputational simulation/modeling·DateSep 20, 2024

Cancer Cooperative Group leaders propose a re-engineering of the nation’s correlative science program for cancer

The Cancer Cooperative Group System is being re-engineered to bring new money to correlative science research through public-private partnerships, aiming to remove barriers for researchers to access biological samples. This will facilitate the integration of innovative science into cancer clinical trials.

SourceECOG-ACRIN Cancer Research Group·JournalJournal of Clinical Oncology·TypeCommentary/editorial·DateSep 18, 2024

Artificial intelligence improves lung cancer diagnosis

A new AI-based digital platform has been developed to analyze tissue sections from lung cancer patients, making diagnosis faster and more accurate. The platform uses algorithms that enable fully automated analysis of digitized tissue samples, allowing for personalized therapy based on molecularly specific genetic changes.

SourceUniversity of Cologne·JournalCell Reports Medicine·TypeImaging analysis·DateAug 23, 2024

Recent study reveals key immune cells as critical factors in lung cancer prognosis

A recent study published in Frontiers in Immunology highlights the crucial role of tissue-resident memory T cells in non-small cell lung cancer. The research found that these cells can significantly impact patient outcomes and guide personalized treatment strategies, particularly those involving immunotherapy.

SourceTerasaki Institute for Biomedical Innovation·JournalFrontiers in Immunology·TypeData/statistical analysis·DateJul 30, 2024

Algorithm helps doctors identify more aggressive types of basal cell carcinoma

A new clinical algorithm developed at the University of Gothenburg can accurately identify highly aggressive forms of basal cell carcinoma. The algorithm uses a combination of clinical and dermoscopic images to distinguish between low-risk and high-risk tumors, allowing for more effective treatment and better patient outcomes.

SourceUniversity of Gothenburg·JournalDermatology Practical & Conceptual·TypeObservational study·DateJul 30, 2024

Nature inspires a breakthrough: scientists develop revolutionary egg white-based bioink for advanced tissue engineering

Terasaki Institute scientists have created a novel bioink derived from egg whites, offering abundant proteins and excellent biocompatibility. This breakthrough technology has the potential to create more accurate tissue models for drug testing and develop functional tissue replacements for regenerative medicine applications.

SourceTerasaki Institute for Biomedical Innovation·JournalAdvanced Functional Materials·TypeExperimental study·DateJul 29, 2024

New technique could help treat aggressive brain tumors

Researchers have developed a new technique called burst sine wave electroporation (B-SWE) that can disrupt the blood-brain barrier around brain tumors without causing significant damage to healthy tissue. This method shows promise for treating aggressive brain cancers like glioblastoma, which currently have limited treatment options.

SourceVirginia Tech·JournalAPL Bioengineering·DateJul 17, 2024

Key driver for epithelial cancer development identified

A distinct TNF-α signaling program has been identified as a key driver of epithelial cancer development, contributing to cell proliferation and invasion. The researchers found that this program is active in both normal tissues and tumors, but its level of activity correlates with tumor aggressiveness.

SourceUniversity of Zurich·JournalNature·TypeExperimental study·DateJul 17, 2024

Roles of PEDF in exercise-induced suppression of senescence and its impact on lung pathology in mice

The study found that exercise increased PEDF levels in skeletal muscles and suppressed senescence markers in the lungs. PEDF also reduced senescence markers in multiple tissues and attenuated decline in respiratory function in pulmonary emphysema mouse model, suggesting its potential as a therapeutic agent for age-related diseases.

SourceImpact Journals LLC·JournalAging-US·TypeObservational study·DateJul 16, 2024

Novel blood test helps improve cancer treatments

A new liquid biopsy method analyzes gene fragments in the bloodstream to detect and track cancer, enabling oncologists to tailor treatment approaches to individual patients. This non-invasive test can help monitor treatment success, detect cancer recurrence, and improve patient quality of life.

SourceUniversity of Zurich·JournalRadiotherapy and Oncology·TypeExperimental study·DateJul 1, 2024

Global consensus for sarcopenia

A new global definition of sarcopenia is proposed, aiming to unify research and clinical practice. The definition may help identify low muscle mass or strength in older people, increasing the risk of poor outcomes such as fragility and disability.

SourceImpact Journals LLC·JournalAging-US·TypeCommentary/editorial·DateJun 26, 2024

3D maps of diseased tissues at subcellular precision

A platform called Open-ST enables scientists to reconstruct gene expression in cells within a tissue in three dimensions, capturing molecular and (sub)cellular structures. The platform was used to study cell types at subcellular resolution in tissues from mice brains, tumor tissue, and healthy lymph nodes, providing insights into cance...

SourceMax Delbrück Center for Molecular Medicine in the Helmholtz Association·JournalCell·TypeComputational simulation/modeling·DateJun 24, 2024

AI model may yield better outcomes for prostate cancer

A new AI model has been shown to significantly improve the accuracy of diagnosing prostate cancer by 45 times compared to doctors' measurements alone. The system assists in mapping out the boundaries of cancerous tissue, reducing the risk of underestimation and enabling more precise treatment planning and effective surgical procedures.

Body’s ‘message in a bottle’ delivers targeted cancer treatment

A new study published in Nature Biomedical Engineering shows that targeted cancer treatment using antibody-displaying extracellular vesicles reduces tumour growth and improves survival in mice. The treatment has the potential to be used against other diseases and cancer types, offering a more effective and fewer side effects compared t...

SourceKarolinska Institutet·JournalNature Biomedical Engineering·TypeExperimental study·DateMay 20, 2024

Hyperspectral dark-field microscopy for rapid and accurate identification of cancerous tissues

Researchers have developed a new imaging technique that rapidly and accurately identifies cancerous tissues in breast samples. The method uses machine learning algorithms trained on hyperspectral dark-field microscopy data to pinpoint regions of invasive ductal carcinoma and invasive mucinous carcinoma.

SourceSPIE--International Society for Optics and Photonics·JournalJournal of Biomedical Optics·DateMay 8, 2024

Four state-of-the-art, artificial intelligence search engines for histopathology images may not be ready for clinical use

Research suggests that four proposed AI search engines for automating search and retrieval of digital histopathology slides have inadequate performance for routine clinical care. The algorithms showed less than 50% accuracy in some cases, highlighting the need for rigorous external validations and standardization before clinical adoption.

SourceUniversity of California - Los Angeles Health Sciences·JournalNEJM AI·TypeImaging analysis·DateMay 2, 2024